Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Canaccord hikes Aberdeen price target on Swip deal

Canaccord hikes Aberdeen price target on Swip deal

Canaccord Genuity has hiked its price target on Aberdeen after inspecting the firm's £550 million acquisition of Scottish Widows Investment Partnership (Swip).

While outflows at Swip has caused concern some quarters, Canaccord analysts Arun Melmane and Robin Savage believe this is largely due to its former parent - state-controlled Lloyds - having to deal with more important issues.     

'We attribute Swip’s recent outflows to a lack of focus within Lloyds as management has dealt with more pressing issues. The focus of Aberdeen’s management team on asset gathering is likely to prove beneficial to AUM growth,' the pair said in a note.

Ultimately Melmane and Savage believe the deal, which will see Lloyds take a 10% stake in Aberdeen, will be beneficial through the long-term relationship between the pair. 

They also highlight the diversification benefits to Martin Gilbert's (pictured) firm.

Performance has been soggy in emerging markets of late given speculation around Fed tapering and the expected impact on asset pricing from the pull back of liquidity,' Melmane and Savage said.

'The diversification that Swip brings should mitigate some of the recent EM-related volatility the stock has seen (although Aberdeen remains an EM focused asset manager).'

Canaccord's stance opposes that of a number of other analysts, including investment banks Credit Suisse and HSBC and stockbroker Peel Hunt, who downgraded their buy ratings on Aberdeen to neutral before Christmas.

In its note, Credit Suisse voiced concern about how much revenue the Swip deal would bring in, while Peel Hunt believed the integration of the business would be a risk and said it preferred to see organic growth at the firm.

In weak day for markets the Canaccord note offered little support to Aberdeen's share price. At 2.15pm it had lost 15.3p, or 3.1%, to sit on 475.7p, around 25p shy of its 52-week high

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Biotech Growth: we will ride out this storm

Biotech Growth: we will ride out this storm

Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.

Play Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

In our first Sector Spotlight of the year we explore UK equities on the back of the extreme market turbulence in 2016.

Play Picton: the UK property hotspots for rental income

Picton: the UK property hotspots for rental income

Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.

Your Business: Cover Star Club

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

In a buyers’ market for off-the-peg discretionary management, self-funded start-ups begin at an inherent disadvantage

Wealth Manager on Twitter